Study of Human Placenta-derived Cells (PDA001) to Evaluate the Safety and Effectiveness for Patients With Ischemic Stroke

Clinical trial NCT01310114 · TERMINATED

Trial details

NCT number: NCT01310114
Sponsor: Celularity Incorporated
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Stroke, Acute Middle Cerebral Artery Stroke Posterior Cerebral Artery Stroke

Start date: 2011-03-01
Primary completion: 2013-03-01
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.